PubRank

A Poveda

Author PubWeight™ 26.30‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 2004 consensus statements on the management of ovarian cancer: final document of the 3rd International Gynecologic Cancer Intergroup Ovarian Cancer Consensus Conference (GCIG OCCC 2004). Ann Oncol 2005 2.33
2 Phase III randomised study to evaluate the role of adjuvant pelvic radiotherapy in the treatment of uterine sarcomas stages I and II: an European Organisation for Research and Treatment of Cancer Gynaecological Cancer Group Study (protocol 55874). Eur J Cancer 2008 2.07
3 Phase II trial of first-line high-dose ifosfamide in advanced soft tissue sarcomas of the adult: a study of the Spanish Group for Research on Sarcomas (GEIS) Ann Oncol 1998 1.60
4 Advanced ovarian cancer: phase III randomized study of sequential cisplatin-topotecan and carboplatin-paclitaxel vs carboplatin-paclitaxel. J Natl Cancer Inst 2010 1.55
5 Predictive impact of DNA repair functionality on clinical outcome of advanced sarcoma patients treated with trabectedin: a retrospective multicentric study. Eur J Cancer 2011 1.27
6 Trabectedin plus pegylated liposomal doxorubicin in relapsed ovarian cancer delays third-line chemotherapy and prolongs the platinum-free interval. Ann Oncol 2010 1.15
7 Bromodomain factor 1 (Bdf1) protein interacts with histones. FEBS Lett 2001 1.09
8 Doxorubicin versus doxorubicin and cisplatin in endometrial carcinoma: definitive results of a randomised study (55872) by the EORTC Gynaecological Cancer Group. Ann Oncol 2003 1.04
9 Structural basis for chitin recognition by defense proteins: GlcNAc residues are bound in a multivalent fashion by extended binding sites in hevein domains. Chem Biol 2000 0.97
10 Phase II randomized study of trabectedin given as two different every 3 weeks dose schedules (1.5 mg/m2 24 h or 1.3 mg/m2 3 h) to patients with relapsed, platinum-sensitive, advanced ovarian cancer. Ann Oncol 2009 0.94
11 Prognostic time dependence of deletions affecting codons 557 and/or 558 of KIT gene for relapse-free survival (RFS) in localized GIST: a Spanish Group for Sarcoma Research (GEIS) Study. Ann Oncol 2010 0.92
12 High-dose DTIC in advanced soft-tissue sarcomas in the adult. A phase II study of the E.O.R.T.C. Soft Tissue and Bone Sarcoma Group. Ann Oncol 1991 0.90
13 The conformation of C-glycosyl compounds. Adv Carbohydr Chem Biochem 2000 0.89
14 Free and protein-bound carbohydrate structures. Curr Opin Struct Biol 1999 0.86
15 Germ cell tumours of the ovary. Clin Transl Oncol 2007 0.86
16 Bleomycin, methotrexate, and CCNU in locally advanced or recurrent, inoperable, squamous-cell carcinoma of the vulva: an EORTC Gynaecological Cancer Cooperative Group Study. European Organization for Research and Treatment of Cancer. Gynecol Oncol 2001 0.85
17 Phase II study of miltefosine (hexadecylphosphocholine) in advanced soft tissue sarcomas of the adult--an EORTC Soft Tissue and Bone Sarcoma Group Study. Eur J Cancer 1993 0.84
18 Phase I study of mitonafide in solid tumors. Invest New Drugs 1992 0.84
19 Structure of complex cell wall polysaccharides isolated from Trichoderma and Hypocrea species. Carbohydr Res 1997 0.83
20 Electrophoretic behavior and size distribution of the acidic polysaccharides produced by the bacteria Bradyrhizobium (Chamaecytisus) strain BGA-1 and Bradyrhizobium japonicum USDA 110. Electrophoresis 1998 0.83
21 Value of FDG-PET for monitoring treatment response in patients with advanced GIST refractory to high-dose imatinib. A multicenter GEIS study. Q J Nucl Med Mol Imaging 2010 0.82
22 Phase II of oral gimatecan in patients with recurrent epithelial ovarian, fallopian tube or peritoneal cancer, previously treated with platinum and taxanes. Ann Oncol 2009 0.80
23 Clinical trials in ovarian carcinoma: requirements for standard approaches and regimens. Ann Oncol 2005 0.80
24 3rd International Ovarian Cancer Consensus Conference: outstanding issues for future consideration. Ann Oncol 2005 0.77
25 Phase I/II trial of doxorubicin and fixed dose-rate infusion gemcitabine in advanced soft tissue sarcomas: a GEIS study. Br J Cancer 2006 0.75
26 Dose-escalated paclitaxel in 1-hour infusion with a fixed dose of cisplatin in previously untreated advanced ovarian cancer: a phase II trial of the Spanish Group for Ovarian Cancer. Semin Oncol 1997 0.75
27 [Malposition of the great arteries. Is this term a valid one?]. Arch Inst Cardiol Mex 1986 0.75
28 Activity of doxorubicin after high-dose ifosfamide in adult patients with advanced soft tissue sarcoma: a study of the Spanish Group for Research on Sarcomas (GEIS). Ann Oncol 1998 0.75